100 related articles for article (PubMed ID: 6998408)
21. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
[TBL] [Abstract][Full Text] [Related]
22. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
[TBL] [Abstract][Full Text] [Related]
23. Major histocompatibility complex (MHC)-I and MHC-II expression in Hodgkin's disease in relation to the presence of Epstein-Barr Virus (EBV).
Tzardi M; Kouvidou C; Papakonstantinou E; Datseris G; Darivianaki K; Karidi E; Eliopoulos G; Delidis G; Rontogianni D; Kanavaros P
Anticancer Res; 1996; 16(2):827-31. PubMed ID: 8687136
[TBL] [Abstract][Full Text] [Related]
24. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
Glasová M; Koníková E; Stasáková J; Babusíková O
Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
[TBL] [Abstract][Full Text] [Related]
25. The presence of HLA-DR antigens on lactating human breast epithelium and milk fat globule membranes.
Newman RA; Ormerod MG; Greaves MF
Clin Exp Immunol; 1980 Sep; 41(3):478-86. PubMed ID: 7002399
[TBL] [Abstract][Full Text] [Related]
26. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
[TBL] [Abstract][Full Text] [Related]
27. Humoral cross immunity in patients with malignant tumors.
Harlozinska A; Albert Z; Richter R; Singer Z; Salwa J
Arch Immunol Ther Exp (Warsz); 1971; 19(6):835-49. PubMed ID: 4946994
[No Abstract] [Full Text] [Related]
28. Immunophenotypic characterization of lymphomas from the mediastinum of young ferrets.
Coleman LA; Erdman SE; Schrenzel MD; Fox JG
Am J Vet Res; 1998 Oct; 59(10):1281-6. PubMed ID: 9781462
[TBL] [Abstract][Full Text] [Related]
29. Characterization and expression of CT45 in Hodgkin's lymphoma.
Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R
Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565
[TBL] [Abstract][Full Text] [Related]
30. [Early diagnosis of leukaemic transformation of malignant non-hodgkin lymphoma in childhood (author's transl)].
Schwenk HU; Willital G
Dtsch Med Wochenschr; 1976 Mar; 101(12):450-4. PubMed ID: 1082810
[TBL] [Abstract][Full Text] [Related]
31. Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells.
Würflein D; Dechant M; Stockmeyer B; Tutt AL; Hu P; Repp R; Kalden JR; van de Winkel JG; Epstein AL; Valerius T; Glennie M; Gramatzki M
Cancer Res; 1998 Jul; 58(14):3051-8. PubMed ID: 9679970
[TBL] [Abstract][Full Text] [Related]
32. T-cell lymphoma following Hodgkin's disease.
Gowitt GT; Chan WC; Brynes RK; Heffner LT
Cancer; 1985 Sep; 56(5):1191-6. PubMed ID: 3874686
[TBL] [Abstract][Full Text] [Related]
33. B lymphocyte antigens in the differential diagnosis of human neoplasia.
Kadin ME; Billing RJ
Blood; 1978 May; 51(5):813-23. PubMed ID: 346089
[TBL] [Abstract][Full Text] [Related]
34. Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markers.
Bergmann L; Mitrou PS; Cherdron T; Holloway K; Jost J; Timm V; Zerth G
Scand J Haematol; 1982 Sep; 29(3):224-34. PubMed ID: 6983113
[TBL] [Abstract][Full Text] [Related]
35. Identification of cells expressing T and p28,33 (Ia-like) antigens in sections of human lymphoid tissue.
Seymour GJ; Greaves MF; Janossy G
Clin Exp Immunol; 1980 Jan; 39(1):66-75. PubMed ID: 6993067
[TBL] [Abstract][Full Text] [Related]
36. I, i and IT antigens in lymphoma, Hodgkin's disease and multiple myeloma.
Joshi SR; Advani SH; Bhatia HM
Indian J Med Res; 1980 Nov; 72():715-20. PubMed ID: 7203574
[No Abstract] [Full Text] [Related]
37. Serum levels of second component of complement in cancer patients.
Southam CM; Siegel AH
J Immunol; 1966 Sep; 97(3):331-7. PubMed ID: 5332649
[No Abstract] [Full Text] [Related]
38. Monoclonal antibodies in the histopathological diagnosis of non-Hodgkin lymphomas.
Meijer CJ; Willemze R; Mullink H; Henzen-Logmans SC; Van der Valk P
Neth J Med; 1985; 28(3):138-41. PubMed ID: 3872419
[No Abstract] [Full Text] [Related]
39. [Six cases of Ia-like antigen positive T cell lymphomas with skin lesions (author's transl)].
Nagatani T; Nakajima H; Nagai R; Minato K; Shimoyama M
Nihon Hifuka Gakkai Zasshi; 1981 Jun; 91(7):739-49. PubMed ID: 6977052
[No Abstract] [Full Text] [Related]
40. [Expression of HLA-DR antigens (Ia-like antigens) in the cornea].
Gronemeyer U; Stein H; Gerdes J
Fortschr Ophthalmol; 1983; 80(4):345-7. PubMed ID: 6354897
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
